AI Dynamics

Global AI News Aggregator

Recursion Pharma acquires Valence AI after seed funding round

In late '19 I Twitter DM'd @_danielcohen CEO of @valence_ai
: "Just checked out Valence and it sounds interesting 🙂 The kind of stuff I like." Today, @RecursionPharma is acquiring @valence_ai 1.5 years after @airstreet and @fiftyyears a Seed round. Congrats to both teams!

→ View original post on X — @nathanbenaich,

Commentaires

Leave a Reply

Your email address will not be published. Required fields are marked *